Cargando…
Therapies for Prevention and Treatment of Alzheimer's Disease
Alzheimer's disease (AD) is the most common cause of dementia associated with a progressive neurodegenerative disorder, with a prevalence of 44 million people throughout the world in 2015, and this figure is estimated to double by 2050. This disease is characterized by blood-brain barrier disru...
Autores principales: | Mendiola-Precoma, J., Berumen, L. C., Padilla, K., Garcia-Alcocer, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980501/ https://www.ncbi.nlm.nih.gov/pubmed/27547756 http://dx.doi.org/10.1155/2016/2589276 |
Ejemplares similares
-
“Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease”
por: Rodríguez-Cruz, Alfredo, et al.
Publicado: (2019) -
Physical exercise in the prevention and treatment of Alzheimer's disease
por: De la Rosa, Adrian, et al.
Publicado: (2020) -
Serotonin Receptors in Hippocampus
por: Berumen, Laura Cristina, et al.
Publicado: (2012) -
The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021) -
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
por: Yang, Zhenqi, et al.
Publicado: (2023)